SUBLOCADE® (buprenorphine extended-release) Injection

About Indivior PLC

Indivior PLC is a leader in addiction medicine, dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. The company's mission centers on delivering life-changing medicines and digital therapeutics to patients with substance use disorders and co-occurring mental illnesses. Its commercial success is anchored by SUBOXONE® film, and it is strategically expanding its portfolio with novel long-acting injectables like SUBLOCADE® and PERSERIS®, and exploring next-generation treatments. Indivior operates as a public company, navigating a complex regulatory and competitive landscape while addressing one of society's most pressing public health challenges.

Therapeutic Areas

Other Opioid Use Disorder (OUD) Maintenance Treatment Drugs